2021 was a successful year for AddLife, with seven acquisitions and an all-time high in revenue and profit. Sales increased by 52 percent, of which organic growth amounted to 11 percent. The acquisitions contributed to total annual sales of approximately SEK 3,300 million.
A leading player in Life Science
AddLife is a listed Swedish Medtech company active on the European market. AddLife owns and acquires companies in niche segments with offerings aimed primarily at the healthcare sector, from research to medical care. The subsidiaries are divided into two business areas. Labtech offers products, solutions and a wide range of diagnostic services, biomedical research and laboratory analysis. Medtech offers products, solutions and services in medical technology and home care.
AddLife's vision is to improve people's lives by being a leading and value-creating player in Life Science. We stand for responsible business where sustainability is an integral part of the business value. We take our responsibility for sustainability throughout the supply chain as an employer, producer and distributor as well as a market participant.
AddLife from a sustainability perspective
Sustainability is a central part of AddLife's vision to improve people's life by being a leading, value-creating player in Life Sciences. We embrace responsible business practices, where sustainability is an integral part of our business value. We accept our responsibility for sustainability throughout the supply chain as employer, producer and distributor, as well as in our role as a market participant.